AMG-220

N/A

Report date: 2022/08/30 20:00:42

Base Information

Drug NameAMG-220
Drug Alias NameC-326AMG-220
ClassificationBiologics
Mechanisms of ActionInterleukin-6 inhibitors
TargetsInterleukin-6
Therapy Area/IndicationsCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvidia
Active IndicationsN/A
Inactive IndicationsCrohn Disease

Other Information

ATC CodeN/A
Related LinksN/A